- Increased industry competition; Decreasing average industry profit margins; Risks associated with new product and specialized technology development; Environmental protection risks; Management risks associated with company expansion; Exchange rate fluctuations; Goodwill impairment risks; Human resource risks
康芝药业股份有限公司
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, 康芝药业股份有限公司 disclosed greenhouse gas emissions of 1.8K tCO2e (Hainan base). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
1.8K tCO2e (Hainan base)
2023
Renewable Energy
14.6% (Hebei base)
of total energy
Water Usage
67.2K tons (Hainan base)
2023
Waste
22.71 tons (Hainan base)
2023
Energy Use
4.2M kWh (Hainan base)
2023
✅ Reported Environmental Achievements
- Reduced water consumption by approximately 500 tons in Hebei base; Reduced electricity consumption by 47,000 kWh and natural gas consumption by 35,900 cubic meters in Hebei base; Hainan base achieved 2,063,386 kWh of photovoltaic power generation, reducing carbon dioxide emissions by 2057.2 tons and saving 1,722,400.36 yuan in costs.
- Hainan base's water, electricity, and gas energy consumption index target was 170 yuan/10,000 yuan of output value, while the actual completion index was 133 yuan/10,000 yuan of output value.
🌱 ESG Focus Areas
EnvironmentSocialGovernance